Explore 3 Stock Ideas & Industry Insights Download Free Report

News

IBRX, ETON, CDNA, GTBP and OTLK Put Biotech and Health Technology in the Nasdaq Composite Spotlight in September 2026

Biotech in 2026 is not one story but many, and this cluster captures the spread. On one end sit companies converting approvals into real, growing revenue; on the other, developers whose science may be promising but whose balance sheets are thin enough to threaten …

Nitish Kishor | 15 September 2026

Why INBS, DYAI, SERA, SGRY and AHCO Make Healthcare Services a Nasdaq Theme to Watch

● Intelligent Bio Solutions submitted its FDA 510(k) package for the Intelligent Fingerprinting Drug Screening System on September 9, 2026, while carrying going-concern language and about $6.86 million in cash.

Nitish Kishor | 15 September 2026

KMTS, FENC, PHVS, LGND and VERA Bring Biotech and Health Technology Into Focus for the Nasdaq Composite in September 2026

Healthcare is the most crowded neighborhood in theNasdaqComposite, and it is also the most fragmented. Within a single sector you can find a device maker scaling revenue at breakneck speed, a small pharma that just turned its first profit, a clinical-stage biotech living from …

Nitish Kishor | 15 September 2026

LQDA, RNXT, KRYS, TENX and NXTC Are Five Biotech and Health Technology Stocks to Watch in the Nasdaq Composite in September 2026

Biotech in September 2026 is a market of two moods. Companies with approved products and real revenue are being rewarded for durability, while pre-revenue names live and die on single data points. Liquidia Corporation (NASDAQ:LQDA), RenovoRx (NASDAQ:RNXT), Krystal Biotech (NASDAQ:KRYS), Tenax Therapeutics (NASDAQ:TENX) and …

Nitish Kishor | 15 September 2026

LXRX, VIR, FATE, CCCC and PTGX Bring Biotech and Health Technology Into Focus for the Nasdaq Composite in September 2026

TheNasdaqComposite has always leaned on its technology giants, but underneath the megacaps sits a crowded field of clinical-stage biotech and health-technology names that trade on catalysts rather thanEarningsmultiples. September 2026 is a useful moment to look closely at five of them, because they span …

Nitish Kishor | 15 September 2026

AKTX, IDXX, ALLR, APVO and REVB Are Five Biotech and Health Technology Stocks to Watch in the Nasdaq Composite in September 2026

Grouping these five tickers together is an exercise in contrast, not comparison. IDEXX Laboratories is a multi-billion-dollar diagnostics compounder with a raised full-year outlook. The other four, Akari Therapeutics, Allarity Therapeutics, Aptevo Therapeutics and Revelation Biosciences, are clinical-stage micro-caps whose value rests on trial …

Nitish Kishor | 15 September 2026

ARWR, WHWK, CGEM, DRIO and MRVI Could Be Key Biotech and Health Technology Names on the Nasdaq Composite in September 2026

Biotech and health technology rarely move as one. On any given week theNasdaqComposite houses companies chasing a first product approval alongside others fighting to stay listed. Arrowhead Pharmaceuticals (NASDAQ:ARWR), Whitehawk Therapeutics (NASDAQ:WHWK), Cullinan Therapeutics (NASDAQ:CGEM), DarioHealth (NASDAQ:DRIO) and Maravai LifeSciences (NASDAQ:MRVI) illustrate that spread.

Nitish Kishor | 15 September 2026

5 Silver Mining Stocks in Focus as the Fed Prepares to Hike

Pan American Silver (NYSE:PAAS): Silver's Largest Pure Play Closes a USD 500 Million-Plus Juanicipio Deal

Nitish Kishor | 15 September 2026

5 Gold Mining Stocks in Focus as the Fed Prepares to Hike

Newmont Corporation (NYSE:NEM): Record Quarter FreeCash Flowof USD 2.2 Billion and a Landmark Nevada Settlement

Nitish Kishor | 15 September 2026

Investor Note: What Really Matters at Wednesday's Fed Meeting

This is a positioning guide, not a recommendation to buy or sell anything specific. The main point: theInterest Ratehike everyone is expecting on Wednesday is the least interesting part of the meeting. What actually moves markets is everything said around it.

Nitish Kishor | 15 September 2026
Support

Hi! How can we help you today?

Loading…